table of content
1 Introduction to Research & Analysis Reports
1.1 Active Pharmaceutical Ingredients (API) CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Active Pharmaceutical Ingredients (API) CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Active Pharmaceutical Ingredients (API) CDMO Overall Market Size
2.1 Global Active Pharmaceutical Ingredients (API) CDMO Market Size: 2023 VS 2030
2.2 Global Active Pharmaceutical Ingredients (API) CDMO Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Active Pharmaceutical Ingredients (API) CDMO Players in Global Market
3.2 Top Global Active Pharmaceutical Ingredients (API) CDMO Companies Ranked by Revenue
3.3 Global Active Pharmaceutical Ingredients (API) CDMO Revenue by Companies
3.4 Top 3 and Top 5 Active Pharmaceutical Ingredients (API) CDMO Companies in Global Market, by Revenue in 2023
3.5 Global Companies Active Pharmaceutical Ingredients (API) CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Active Pharmaceutical Ingredients (API) CDMO Players in Global Market
3.6.1 List of Global Tier 1 Active Pharmaceutical Ingredients (API) CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Active Pharmaceutical Ingredients (API) CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Active Pharmaceutical Ingredients (API) CDMO Market Size Markets, 2023 & 2030
4.1.2 Macromolecular API
4.1.3 Small Molecule API
4.2 By Type - Global Active Pharmaceutical Ingredients (API) CDMO Revenue & Forecasts
4.2.1 By Type - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2024
4.2.2 By Type - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2025-2030
4.2.3 By Type - Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Active Pharmaceutical Ingredients (API) CDMO Market Size, 2023 & 2030
5.1.2 Clinical
5.1.3 Commercial
5.1.4 Others
5.2 By Application - Global Active Pharmaceutical Ingredients (API) CDMO Revenue & Forecasts
5.2.1 By Application - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2024
5.2.2 By Application - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2025-2030
5.2.3 By Application - Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Active Pharmaceutical Ingredients (API) CDMO Market Size, 2023 & 2030
6.2 By Region - Global Active Pharmaceutical Ingredients (API) CDMO Revenue & Forecasts
6.2.1 By Region - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2024
6.2.2 By Region - Global Active Pharmaceutical Ingredients (API) CDMO Revenue, 2025-2030
6.2.3 By Region - Global Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2030
6.3.2 US Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.3.3 Canada Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.3.4 Mexico Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2030
6.4.2 Germany Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4.3 France Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4.4 U.K. Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4.5 Italy Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4.6 Russia Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4.7 Nordic Countries Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.4.8 Benelux Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2030
6.5.2 China Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.5.3 Japan Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.5.4 South Korea Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.5.5 Southeast Asia Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.5.6 India Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2030
6.6.2 Brazil Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.6.3 Argentina Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) CDMO Revenue, 2019-2030
6.7.2 Turkey Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.7.3 Israel Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.7.4 Saudi Arabia Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
6.7.5 UAE Active Pharmaceutical Ingredients (API) CDMO Market Size, 2019-2030
7 Active Pharmaceutical Ingredients (API) CDMO Companies Profiles
7.1 Recipharm
7.1.1 Recipharm Company Summary
7.1.2 Recipharm Business Overview
7.1.3 Recipharm Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.1.4 Recipharm Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.1.5 Recipharm Key News & Latest Developments
7.2 Cambrex Corporation
7.2.1 Cambrex Corporation Company Summary
7.2.2 Cambrex Corporation Business Overview
7.2.3 Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.2.4 Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.2.5 Cambrex Corporation Key News & Latest Developments
7.3 Patheon (Thermo Fisher Scientific)
7.3.1 Patheon (Thermo Fisher Scientific) Company Summary
7.3.2 Patheon (Thermo Fisher Scientific) Business Overview
7.3.3 Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.3.4 Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.3.5 Patheon (Thermo Fisher Scientific) Key News & Latest Developments
7.4 CordenPharma
7.4.1 CordenPharma Company Summary
7.4.2 CordenPharma Business Overview
7.4.3 CordenPharma Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.4.4 CordenPharma Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.4.5 CordenPharma Key News & Latest Developments
7.5 Lonza
7.5.1 Lonza Company Summary
7.5.2 Lonza Business Overview
7.5.3 Lonza Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.5.4 Lonza Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.5.5 Lonza Key News & Latest Developments
7.6 Siegfried
7.6.1 Siegfried Company Summary
7.6.2 Siegfried Business Overview
7.6.3 Siegfried Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.6.4 Siegfried Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.6.5 Siegfried Key News & Latest Developments
7.7 Catalent
7.7.1 Catalent Company Summary
7.7.2 Catalent Business Overview
7.7.3 Catalent Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.7.4 Catalent Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.7.5 Catalent Key News & Latest Developments
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Company Summary
7.8.2 Boehringer Ingelheim Business Overview
7.8.3 Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.8.4 Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.8.5 Boehringer Ingelheim Key News & Latest Developments
7.9 Piramal Group
7.9.1 Piramal Group Company Summary
7.9.2 Piramal Group Business Overview
7.9.3 Piramal Group Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.9.4 Piramal Group Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.9.5 Piramal Group Key News & Latest Developments
7.10 AbbVie
7.10.1 AbbVie Company Summary
7.10.2 AbbVie Business Overview
7.10.3 AbbVie Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.10.4 AbbVie Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.10.5 AbbVie Key News & Latest Developments
7.11 SGS Quay Pharmaceuticals
7.11.1 SGS Quay Pharmaceuticals Company Summary
7.11.2 SGS Quay Pharmaceuticals Business Overview
7.11.3 SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.11.4 SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.11.5 SGS Quay Pharmaceuticals Key News & Latest Developments
7.12 Aenova Group
7.12.1 Aenova Group Company Summary
7.12.2 Aenova Group Business Overview
7.12.3 Aenova Group Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.12.4 Aenova Group Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.12.5 Aenova Group Key News & Latest Developments
7.13 Curia
7.13.1 Curia Company Summary
7.13.2 Curia Business Overview
7.13.3 Curia Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.13.4 Curia Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.13.5 Curia Key News & Latest Developments
7.14 Sterling Pharma Solutions
7.14.1 Sterling Pharma Solutions Company Summary
7.14.2 Sterling Pharma Solutions Business Overview
7.14.3 Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.14.4 Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.14.5 Sterling Pharma Solutions Key News & Latest Developments
7.15 Eurofins CDMO
7.15.1 Eurofins CDMO Company Summary
7.15.2 Eurofins CDMO Business Overview
7.15.3 Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Major Product Offerings
7.15.4 Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Revenue in Global Market (2019-2024)
7.15.5 Eurofins CDMO Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
